Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016
- PMID: 30307490
- DOI: 10.1093/cid/ciy737
Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016
Abstract
Background: To date, no study has examined influenza vaccine effectiveness (IVE) against laboratory-confirmed influenza-associated hospitalizations during pregnancy.
Methods: The Pregnancy Influenza Vaccine Effectiveness Network (PREVENT) consisted of public health or healthcare systems with integrated laboratory, medical, and vaccination records in Australia, Canada (Alberta and Ontario), Israel, and the United States (California, Oregon, and Washington). Sites identified pregnant women aged 18 through 50 years whose pregnancies overlapped with local influenza seasons from 2010 through 2016. Administrative data were used to identify hospitalizations with acute respiratory or febrile illness (ARFI) and clinician-ordered real-time reverse transcription polymerase chain reaction (rRT-PCR) testing for influenza viruses. Overall IVE was estimated using the test-negative design and adjusting for site, season, season timing, and high-risk medical conditions.
Results: Among 19450 hospitalizations with an ARFI discharge diagnosis (across 25 site-specific study seasons), only 1030 (6%) of the pregnant women were tested for influenza viruses by rRT-PCR. Approximately half of these women had pneumonia or influenza discharge diagnoses (54%). Influenza A or B virus infections were detected in 598/1030 (58%) of the ARFI hospitalizations with influenza testing. Across sites and seasons, 13% of rRT-PCR-confirmed influenza-positive pregnant women were vaccinated compared with 22% of influenza-negative pregnant women; the adjusted overall IVE was 40% (95% confidence interval = 12%-59%) against influenza-associated hospitalization during pregnancy.
Conclusion: Between 2010 and 2016, influenza vaccines offered moderate protection against laboratory-confirmed influenza-associated hospitalizations during pregnancy, which may further inform the benefits of maternal influenza vaccination programs.
Keywords: hospitalization; influenza; pregnancy; pregnant women; vaccine effectiveness.
Published by Oxford University Press for the Infectious Diseases Society of America 2018.
Comment in
-
Influenza Vaccination During Pregnancy Can Protect Women Against Hospitalization Across Continents.Clin Infect Dis. 2019 Apr 24;68(9):1454-1455. doi: 10.1093/cid/ciy740. Clin Infect Dis. 2019. PMID: 30307481 No abstract available.
-
Reply to Skowronski, De Serres, and Orenstein.Clin Infect Dis. 2019 Aug 30;69(6):1085-1086. doi: 10.1093/cid/ciz115. Clin Infect Dis. 2019. PMID: 30753401 No abstract available.
-
Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation.Clin Infect Dis. 2019 Aug 30;69(6):1084-1085. doi: 10.1093/cid/ciz113. Clin Infect Dis. 2019. PMID: 30753442 Free PMC article. No abstract available.
Similar articles
-
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.Vaccine. 2017 Aug 3;35(34):4298-4306. doi: 10.1016/j.vaccine.2017.06.088. Epub 2017 Jul 11. Vaccine. 2017. PMID: 28709555
-
Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.Vaccine. 2018 Jun 7;36(24):3555-3566. doi: 10.1016/j.vaccine.2017.06.036. Epub 2017 Jun 23. Vaccine. 2018. PMID: 28648543 Free PMC article.
-
Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.J Med Virol. 2016 Nov;88(11):1896-904. doi: 10.1002/jmv.24551. Epub 2016 Apr 26. J Med Virol. 2016. PMID: 27088266
-
Real-world effectiveness of seasonal influenza vaccination and age as effect modifier: A systematic review, meta-analysis and meta-regression of test-negative design studies.Vaccine. 2024 Mar 19;42(8):1883-1891. doi: 10.1016/j.vaccine.2024.02.059. Epub 2024 Feb 28. Vaccine. 2024. PMID: 38423813 Review.
-
Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis.Vaccine. 2020 Mar 23;38(14):2893-2903. doi: 10.1016/j.vaccine.2020.02.049. Epub 2020 Feb 27. Vaccine. 2020. PMID: 32113808 Review.
Cited by
-
Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period - Suzhou City, Jiangsu Province, China, 2018-2023.MMWR Morb Mortal Wkly Rep. 2024 Oct 31;73(43):958-964. doi: 10.15585/mmwr.mm7343a1. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39480696 Free PMC article.
-
Evaluating Factors That Influence Influenza Vaccination Uptake among Pregnant People in a Medically Underserved Area in Washington State.Vaccines (Basel). 2024 Jul 13;12(7):768. doi: 10.3390/vaccines12070768. Vaccines (Basel). 2024. PMID: 39066406 Free PMC article.
-
Summary of the National Advisory Committee on Immunization (NACI) Updated Guidance on Influenza Vaccination During Pregnancy.Can Commun Dis Rep. 2024 Apr 30;50(3-4):86-92. doi: 10.14745/ccdr.v50i34a01. eCollection 2024 Apr 30. Can Commun Dis Rep. 2024. PMID: 38716409 Free PMC article.
-
Effect of maternal vaccination on infant morbidity in Bangladesh.BMC Public Health. 2024 May 2;24(1):1213. doi: 10.1186/s12889-024-18486-x. BMC Public Health. 2024. PMID: 38698353 Free PMC article. Clinical Trial.
-
Knowledge, attitudes, beliefs and practices of pregnant women towards the influenza vaccine in Trinidad.J Family Med Prim Care. 2024 Jan;13(1):182-190. doi: 10.4103/jfmpc.jfmpc_229_23. Epub 2024 Feb 8. J Family Med Prim Care. 2024. PMID: 38482300 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
